Expleo Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Unaudited Standalone And Consolidated ....
EXPLEOSOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Expleo Solutions has informed the exchanges that its Board of Directors will meet on Thursday, November 13, 2025. The key agenda items are to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2025 (i.e., Q2 FY26 and H1 FY26). The filing is a standard regulatory intimation under SEBI listing requirements, signed by the Company Secretary on November 6, 2025. No actual financial numbers have been disclosed in this filing — it only sets the date for the results announcement.
This is a routine pre-results announcement and typically has no direct impact on the stock price. Investors should watch for the actual Q2/H1 FY26 results post the November 13 meeting to assess revenue growth, margins, and earnings trajectory.